摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(2-Phenylethyl)imidazol-4-amine | 1378856-84-8

中文名称
——
中文别名
——
英文名称
3-(2-Phenylethyl)imidazol-4-amine
英文别名
——
3-(2-Phenylethyl)imidazol-4-amine化学式
CAS
1378856-84-8
化学式
C11H13N3
mdl
——
分子量
187.244
InChiKey
JKKFXCRUEZZITE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    14
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.18
  • 拓扑面积:
    43.8
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    3-(2-Phenylethyl)imidazol-4-amine 在 palladium 10% on activated carbon 、 氢气溶剂黄146 作用下, 以 甲醇二氯甲烷 为溶剂, 20.0 ℃ 、101.33 kPa 条件下, 反应 1.33h, 生成 3-phenethyl-3H-imidazo[4,5-b]pyridin-6-amine
    参考文献:
    名称:
    Design, synthesis and transformation of some heteroannulated 3-aminopyridines—purine isosteres with exocyclic nitrogen atom
    摘要:
    The synthesis of 1-deazapurines and isosteres bearing the exocyclic nitrogen atom at position-1 was developed basing on the formal [3+3]-cyclization reaction of nitro-malonaldehyde with the set of electron-excessive aminoheterocycles. Through the functionalization of the purine-like scaffolds synthesized the diversity of compounds furnished in the possition-1 with aryl, alkinyl, and vinyl rests, were obtained. (C) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tet.2012.11.026
  • 作为产物:
    参考文献:
    名称:
    通过 1-取代的 1H-Imidazol-5-胺与 3-Nitro-4H-chromen-4-one 的环缩合反应有效合成 6-Nitro-和 6-Amino-3H-imidazo[4,5-b]pyridines
    摘要:
    3-nitro-4 H-chromen-4-one与原位反应生成1-取代的5-amino-1 H-imidazoles提供了一组1-取代的6-nitro-3 H-imidazo[4,5-B]代表潜在的腺苷脱氨酶 (ADA) 抑制剂的吡啶。硝基的还原导致相应的 6-amino-3 H-imidazo[4,5-B] 吡啶的形成。
    DOI:
    10.1055/s-0030-1258538
点击查看最新优质反应信息

文献信息

  • Design and Synthesis of Polycyclic Imidazole‐Containing N‐ Heterocycles based on CH Activation/Cyclization Reactions
    作者:Viktor O. Iaroshenko、Dmytro Ostrovskyi、Mariia Miliutina、Aneela Maalik、Alexander Villinger、Andrei Tolmachev、Dmitriy M. Volochnyuk、Peter Langer
    DOI:10.1002/adsc.201200221
    日期:2012.9.17
    A new strategy for the synthesis of polycyclic imidazole‐containing N‐heterocycles, based on the two general synthetic ways, namely the Pd(II)‐catalyzed intramolecular arylation via CH/CHal and CH/CH coupling reactions, was developed. The method proposed here enables the synthesis of many fused N‐heterocycles containing purine, 1‐deazapurines and benzimidazole structural units.
    基于两种通用的合成方法,即通过CH / CHal和CH / CH偶联反应,Pd(II)催化的分子内芳基化反应,开发了一种合成多环咪唑N-杂环的新策略。本文提出的方法能够合成许多含有嘌呤,1-去嘌呤苯并咪唑结构单元的稠合N-杂环。
  • Transition-Metal-Catalyzed Arylation of 1-Deazapurines via C–H Bond Activation
    作者:Viktor Iaroshenko、Iftikhar Ali、Satenik Mkrtchyan、Volodymyr Semeniuchenko、Dmytro Ostrovskyi、Peter Langer
    DOI:10.1055/s-0032-1317329
    日期:——
    Transition-metal-catalyzed arylation of imidazo[4,5-b]pyridines (known as 1-deazapurines) is reported. 1-Deazapurines were synthesized from 5-aminoimidazoles, generated in situ by the reaction of methyl N-(cyanomethyl)formimidate with primary amines.
    据报道,过渡属催化的咪唑并 [4,5-b] 吡啶(称为 1-去嘌呤)芳基化。1-嘌呤由 5-咪唑合成,由 N-(甲基)甲亚胺酸甲伯胺反应原位生成。
  • 3-Methoxalylchromone - A Versatile Reagent for the Regioselective Synthesis of 1-Desazapurine
    作者:Viktor Iaroshenko、Peter Langer、Dmytro Ostrovskyi、Iftikhar Ali、Satenik Mkrtchyan、Alexander Villinger、Andrei Tolmachev
    DOI:10.1055/s-0030-1258339
    日期:2011.1
    The reaction of 5-amino-1H-imidazoles with 3-methoxalylchromone provided a set of imidazo[4,5-b]pyridines (1-des­azapurines) bearing the CO2Me substituent at the α-position of the pyridine core. The corresponding acids were synthesized by subsequent hydrolysis of the ester function. Being typical purine isos­teres, 1-desazapurines are considered to be potent pharmacophores, and are widely used in drug design and medicinal chemistry.
    5-amino-1H-imidazoles 与 3-methoxalylchromone 的反应产生了一组咪唑并[4,5-b]吡啶(1-desazapurines),其吡啶核心的 δ 位带有 CO2Me 取代基。随后通过功能合成了相应的酸。作为典型的嘌呤异构体,1-desazapurines 被认为是强效药亲和剂,广泛应用于药物设计和药物化学
查看更多